CoChat

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

Open access
Skates, Steven J., Greene, Mark H., Buys, Saundra S., Mai, Phuong L., Brown, Powel, Piedmonte, Marion, Rodriguez, Gustavo, Schorge, John O., Sherman, Mark, Daly, Mary B., Rutherford, Thomas, Brewster, Wendy R., O'Malley, David M., Partridge, Edward, Boggess, John, Drescher, Charles W., Isaacs, Claudine, Berchuck, Andrew, Domchek, Susan, Davidson, Susan A., Edwards, Robert, Elg, Steven A., Wakeley, Katie, Phillips, Kelly-Anne, Armstrong, Deborah, Horowitz, Ira, Fabian, Carol J., Walker, Joan, Sluss, Patrick M., Welch, William, Minasian, Lori, Horick, Nora K., Kasten, Carol H., Nayfield, Susan, Alberts, David, Finkelstein, Dianne M., Lu, Karen H. · 2017 · Clinical Cancer Research
Cited by 140

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Purpose: Women at familial/genetic ovarian cancer risk often undergo screening despite unproven efficacy. Research suggests each woman has her own CA125 baseline; significant increases above this level may identify cancers earlier than standard 6- to 12-monthly CA125 > 35 U/mL. Experimental Design: Data from prospective Cancer Genetics Network and Gynecologic Oncology Group trials, which screened 3,692 women (13,080 woman-screening years) with a strong breast/ovarian cancer family history or BRCA1/2 mutations, were combined to assess a novel screening strategy. Specifically, serum CA125 q3 months, evaluated using a risk of ovarian cancer algorithm (ROCA), detected significant increases above each subject's baseline, which triggered transvaginal ultrasound. Specificity and positive predictive value (PPV) were compared with levels derived from general population screening (specificity 90%, PPV 10%), and stage-at-detection was compared with historical high-risk controls. Results: Specificity for ultrasound referral was 92% versus 90% (P = 0.0001), and PPV was 4.6% versus 10% (P > 0.10). Eighteen of 19 malignant ovarian neoplasms [prevalent = 4, incident = 6, risk-reducing salpingo-oophorectomy (RRSO) = 9] were detected via screening or RRSO. Among incident cases (which best reflect long-term screening performance), three of six invasive cancers were early-stage (I/II; 50% vs. 10% historical BRCA1 controls; P = 0.016). Six of nine RRSO-related cases were stage I. ROCA flagged three of six (50%) incident cases before CA125 exceeded 35 U/mL. Eight of nine patients with stages 0/I/II ovarian cancer were alive at last follow-up (median 6 years). Conclusions: For screened women at familial/genetic ovarian cancer risk, ROCA q3 months had better early-stage sensitivity at high specificity, and low yet possibly acceptable PPV compared with CA125 > 35 U/mL q6/q12 months, warranting further larger cohort evaluation. Clin Cancer Res; 23(14); 3628–37. ©2017 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-15-2750

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 140

Metadata

Authors
Skates, S. J., Greene, M. H., Buys, S. S., Mai, P. L., Brown, P., Piedmonte, M., Rodriguez, G., Schorge, J. O., Sherman, M., Daly, M. B., Rutherford, T., Brewster, W. R., O'Malley, D. M., Partridge, E., Boggess, J., Drescher, C. W., Isaacs, C., Berchuck, A., Domchek, S., Davidson, S. A., Edwards, R., Elg, S. A., Wakeley, K., Phillips, K.-A., Armstrong, D., Horowitz, I., Fabian, C. J., Walker, J., Sluss, P. M., Welch, W., Minasian, L., Horick, N. K., Kasten, C. H., Nayfield, S., Alberts, D., Finkelstein, D. M., & Lu, K. H.
Venue
Clinical Cancer Research
Published
2017-07-13
Volume
23
Issue
14
Pages
3628-3637
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2584307052
Cited by
140
References
5
FWCI
15.14
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-15-2750
The paper
Skates, S. J., Greene, M. H., Buys, S. S., Mai, P. L., Brown, P., Piedmonte, M., Rodriguez, G., Schorge, J. O., Sherman, M., Daly, M. B., Rutherford, T., Brewster, W. R., O'Malley, D. M., Partridge, E., Boggess, J., Drescher, C. W., Isaacs, C., Berchuck, A., Domchek, S., . . . Lu, K. H. (2017). Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-15-2750

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.